SHILPA MEDICARE LTD.
Cah Flow
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|
Profit Before Tax | -382.80 | 1022.65 | 1950.52 | 1880.52 | 1356.78 |
Adjustment | 1481.47 | 1093.42 | 57.62 | 416.72 | 284.54 |
Changes In working Capital | 1486.79 | -719.91 | -1062.86 | -631.50 | 187.15 |
Cash Flow after changes in Working Capital | 2585.46 | 1396.16 | 945.28 | 1665.75 | 1828.47 |
Cash Flow from Operating Activities | 2261.72 | 1051.33 | 469.28 | 1243.78 | 1467.80 |
Cash Flow from Investing Activities | -2784.84 | -2854.98 | -4042.76 | -2895.18 | -1961.64 |
Cash Flow from Financing Activities | 457.98 | 828.58 | 4363.74 | 1755.02 | 100.60 |
Net Cash Inflow / Outflow | -65.14 | -975.07 | 790.26 | 103.63 | -393.25 |
Opening Cash & Cash Equivalents | 253.39 | 1228.46 | 443.14 | 341.30 | 738.28 |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | NA | NA | NA | NA | NA |
Cash & Cash Equivalent of Subsidiaries under liquidations | NA | NA | NA | NA | NA |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | NA | NA | NA | NA | NA |
Effect of Foreign Exchange Fluctuations | NA | NA | NA | -1.79 | -1.42 |
Closing Cash & Cash Equivalent | 188.25 | 253.39 | 1233.40 | 443.14 | 343.61 |